Company intelligence / Profile preview

My CytoHealth

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

My CytoHealth is a Singapore-based biotechnology company specializing in advanced cell-based therapies and regenerative medicine. The company focuses on the development and commercialization of secretome and exosome-based products derived from umbilical cord-derived mesenchymal stem cells (MSCs). Their primary offerings include treatments for orthopedic conditions like osteoarthritis and aesthetic applications such as skin rejuvenation and hair restoration. By leveraging proprietary Cyto-Secretome technology, My CytoHealth aims to provide non-invasive, cell-free regenerative solutions that harness the natural healing signaling of stem cells.

Therapeutic areas: ImmunologyRheumatologyDermatology
Modalities: Cell therapyExosome-based therapyStem cell therapy
Industry: Biotech

Beyond the preview

Go deeper on My CytoHealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on My CytoHealth.

Explore the full profile